Bristol Myers Squibb to establish facility in Hyderabad

Hyderabad:  Asserting Hyderabad‘s standing as a lifesciences hub, US-based Bristol Myers Squibb, one of the world’s top biopharmaceutical firms, has chosen Hyderabad to set up its Science, Technology and Innovation Centre. It will invest $100 million (about Rs 820 crore) and will employ 1,500 people.

The Centre will take shape by the end of the third quarter this year. This is part of the company’s plans to expand its drug development and IT and digital innovation capabilities.

“I am delighted to welcome Bristol-Myers Squibb to the vibrant ecosystem of Hyderabad. It is indeed a matter of pride that BMS, which is one of the most innovative and world leading biopharmaceutical

companies, has chosen Hyderabad. I strongly believe this partnership with BMS is a strategic one. I am confident that the centre will provide a great opportunity for our talent pool to engage in some highly impactful work,” IT and Industries Minister KT Rama Rao said at the MoU ceremony here on Thursday.